ArticleOncotarget2016

Alveolar rhabdomyosarcoma: morphoproteomics and personalized tumor graft testing further define the biology of PAX3-FKHR(FOXO1) subtype and provide targeted therapeutic options.

Robert E Brown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.